# Grazyna Pulka – FDA Inspection, Mar 24, 2023

Source: https://www.keypedia.com/records/fda_inspections/grazyna-pulka/733d1220-59c5-48c1-8099-9d1dbc1ccaa0
Source feed: FDA_Inspections

> FDA inspection 1204442 of Grazyna Pulka, March 24, 2023. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204442
- Company Name: Grazyna Pulka
- Inspection Date: 2023-03-24
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1275129 - 2025-06-12
- FDA Inspection 961363 - 2016-02-05

## Related Officers

- [Joseph L. Despins](https://www.keypedia.com/people/joseph-l-despins/c84402a8-7ebb-45ab-b1b9-c43a143c5fb8)

Company: https://www.keypedia.com/companies/grazyna-pulka/d80efb59-b170-4e5e-8379-49d7a7f3b49d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c